Several other research analysts have also recently weighed in on the stock. Jefferies Financial Group assumed coverage on shares of USANA Health Sciences in a report on Thursday, August 22nd. They issued a hold rating and a $65.00 price target on the stock. Zacks Investment Research upgraded USANA Health Sciences from a hold rating to a strong-buy rating and set a $86.00 target price for the company in a research report on Saturday, October 26th. Two investment analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. The stock currently has a consensus rating of Buy and an average price target of $74.00.
Shares of NYSE:USNA traded up $1.88 during trading on Tuesday, hitting $76.35. 74,217 shares of the company were exchanged, compared to its average volume of 229,750. USANA Health Sciences has a 52-week low of $58.30 and a 52-week high of $125.61. The stock has a 50 day moving average of $73.43 and a 200 day moving average of $70.27. The company has a market cap of $1.59 billion, a PE ratio of 14.80 and a beta of 0.30.
In other USANA Health Sciences news, CFO G Doug Iiekking sold 1,746 shares of USANA Health Sciences stock in a transaction that occurred on Friday, October 25th. The stock was sold at an average price of $75.33, for a total value of $131,526.18. Following the transaction, the chief financial officer now directly owns 2,032 shares of the company’s stock, valued at approximately $153,070.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Walter Noot sold 1,176 shares of the business’s stock in a transaction that occurred on Thursday, October 24th. The shares were sold at an average price of $75.98, for a total value of $89,352.48. Following the completion of the sale, the chief operating officer now owns 1,444 shares of the company’s stock, valued at approximately $109,715.12. The disclosure for this sale can be found here. Insiders have sold 8,385 shares of company stock worth $617,279 over the last ninety days. Insiders own 42.50% of the company’s stock.
Several institutional investors have recently modified their holdings of USNA. Metropolitan Life Insurance Co NY increased its position in USANA Health Sciences by 20.0% during the 3rd quarter. Metropolitan Life Insurance Co NY now owns 4,876 shares of the company’s stock valued at $333,000 after purchasing an additional 814 shares during the period. Squarepoint Ops LLC lifted its position in shares of USANA Health Sciences by 37.4% in the 3rd quarter. Squarepoint Ops LLC now owns 37,247 shares of the company’s stock worth $2,547,000 after purchasing an additional 10,147 shares during the period. Voloridge Investment Management LLC bought a new stake in shares of USANA Health Sciences during the 3rd quarter valued at about $1,522,000. Barclays PLC boosted its stake in shares of USANA Health Sciences by 1.6% during the 3rd quarter. Barclays PLC now owns 24,660 shares of the company’s stock valued at $1,687,000 after purchasing an additional 398 shares in the last quarter. Finally, Public Employees Retirement System of Ohio boosted its stake in shares of USANA Health Sciences by 44.5% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 14,033 shares of the company’s stock valued at $960,000 after purchasing an additional 4,324 shares in the last quarter. Hedge funds and other institutional investors own 52.87% of the company’s stock.
About USANA Health Sciences
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.
Further Reading: Current Ratio
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.